What’s the Problem?
Jan. 9, 2020 – According to an FDA Recall Notice issued Wednesday, the Nizatidine recall affects the following products:
- 0378-5150-91 Nizatidine Capsules, USP 150mg Bottles of 60 3086746 May 2020
- 0378-5300-93 Nizatidine Capsules, USP 300mg Bottles of 30 3082876 Jan 2020
- 0378-5300-93 Nizatidine Capsules, USP 300mg Bottles of 30 3082877 Jan 2020
No reports of cancer or other serious side effects have been linked to the recalled Nizatidine; however, the drug may be contaminated with NDMA, a highly toxic impurity, so the recall was taken as a precautionary measure.
What is NDMA?
N-nitrosodimethylamine is a environmental contaminant commonly found in water and foods, according to the FDA. NDMA is classified as a known human carcinogen, or cancer-causing substance.
NDMA Side Effects
- Reduced function of the kidneys and lungs
- Abdominal cramps
Amneal Pharmaceuticals Nizatidine Recall
Amneal Pharmaceuticals, LLC, is recalling 3 lots of Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL), over potential contamination with NDMA. The affected Nizatidine was distributed to wholesalers who further distributed to retail pharmacies and consumers nationwide. This recall began on April 15, 2020.
Do I Have a Nizatidine Recall Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Nizatidine Recall Lawsuits. We are handling individual litigation nationwide and currently accepting new cancer cases in all 50 states.
If you or a loved one was diagnosed with cancer after taking Nizatidine, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.